No abstract available
Publication types
-
Case Reports
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antifungal Agents / administration & dosage
-
Antilymphocyte Serum
-
Antineoplastic Agents / administration & dosage
-
Aspergillosis, Allergic Bronchopulmonary / drug therapy
-
Aspergillosis, Allergic Bronchopulmonary / etiology
-
Base Sequence / genetics
-
Bone Marrow Transplantation*
-
DNA, Mitochondrial / genetics
-
Electron Transport / genetics
-
Female
-
Genetic Diseases, Inborn / genetics
-
Genetic Diseases, Inborn / pathology
-
Genetic Diseases, Inborn / therapy*
-
Graft vs Host Disease / etiology
-
Graft vs Host Disease / prevention & control
-
Humans
-
Immunosuppressive Agents / administration & dosage
-
Infant
-
Leukemia, Myeloid / therapy
-
Melphalan / administration & dosage
-
Mitochondrial Diseases / complications
-
Mitochondrial Diseases / genetics
-
Mitochondrial Diseases / pathology
-
Mitochondrial Diseases / therapy*
-
Myeloablative Agonists / administration & dosage
-
Sequence Deletion
-
Syndrome
-
Transplantation Conditioning*
-
Transplantation, Homologous
-
Treatment Failure
-
Vidarabine / analogs & derivatives
Substances
-
Antifungal Agents
-
Antilymphocyte Serum
-
Antineoplastic Agents
-
DNA, Mitochondrial
-
Immunosuppressive Agents
-
Myeloablative Agonists
-
Vidarabine
-
fludarabine
-
Melphalan